Savara Inc Basic Shares Outstanding (Weighted Average)
Savara Inc (SVRA) reported Basic Shares Outstanding (Weighted Average) of 253.57 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- Savara Inc weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 253.57M shares, a 17.16% increase year-over-year.
- Savara Inc weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 253.28M shares, a 17.18% increase year-over-year.
- Savara Inc weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 240.51M shares, a 11.57% increase year-over-year.
- Savara Inc weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 216.46M shares, a 2.18% increase year-over-year.
- Savara Inc weighted average number of shares outstanding, basic for fiscal 2025 was 222.39M shares, a 12.21% increase from fiscal 2024.
- Savara Inc weighted average number of shares outstanding, basic for fiscal 2024 was 198.19M shares, a 19.97% increase from fiscal 2023.
- Savara Inc weighted average number of shares outstanding, basic for fiscal 2023 was 165.20M shares, a 8.14% increase from fiscal 2022.
- Savara Inc weighted average number of shares outstanding, basic for fiscal 2022 was 152.77M shares, a 14.08% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 253.57M shares 10-Q · filed 2026-08-11 | 253.43M shares 10-Q · filed 2026-08-11 | 249.12M shares derived: average of 3 quarters · filed 2026-08-11 | 240.95M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2026-03-31 | 253.28M shares 10-Q · filed 2026-05-12 | 246.89M shares derived: average of 2 quarters · filed 2026-05-12 | 236.75M shares derived: average of 3 quarters · filed 2026-05-12 | 231.67M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-12-31 | 240.51M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 228.48M shares derived: average of 2 quarters · filed 2026-03-13 | 224.47M shares derived: average of 3 quarters · filed 2026-08-11 | 222.39M shares 10-K · filed 2026-03-13 | ||
| 2025-09-30 | 216.46M shares 10-Q · filed 2025-11-12 | 216.45M shares derived: average of 2 quarters · filed 2026-08-11 | 216.35M shares 10-Q · filed 2025-11-12 | 216.15M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-06-30 | 216.43M shares 10-Q · filed 2026-08-11 | 216.29M shares 10-Q · filed 2026-08-11 | 216.05M shares derived: average of 3 quarters · filed 2026-08-11 | 215.00M shares derived: average of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | 216.15M shares 10-Q · filed 2026-05-12 | 215.86M shares derived: average of 2 quarters · filed 2026-05-12 | 214.52M shares derived: average of 3 quarters · filed 2026-05-12 | 206.54M shares derived: average of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | 215.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 213.71M shares derived: average of 2 quarters · filed 2026-03-13 | 203.33M shares derived: average of 3 quarters · filed 2026-03-13 | 198.19M shares 10-K · filed 2026-03-13 | ||
| 2024-09-30 | 211.85M shares 10-Q · filed 2025-11-12 | 197.22M shares derived: average of 2 quarters · filed 2025-11-12 | 192.40M shares 10-Q · filed 2025-11-12 | 194.87M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 182.58M shares 10-Q · filed 2025-08-13 | 182.57M shares 10-Q · filed 2025-08-13 | 189.21M shares derived: average of 3 quarters · filed 2025-08-13 | 185.58M shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 182.55M shares 10-Q · filed 2025-05-13 | 192.52M shares derived: average of 2 quarters · filed 2025-05-13 | 186.58M shares derived: average of 3 quarters · filed 2025-05-13 | 178.13M shares derived: average of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | 202.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 188.59M shares derived: average of 2 quarters · filed 2025-03-27 | 176.66M shares derived: average of 3 quarters · filed 2025-03-27 | 165.20M shares 10-K · filed 2025-03-27 | ||
| 2023-09-30 | 174.70M shares 10-Q · filed 2024-11-12 | 164.34M shares 10-Q · filed 2023-11-09 | 163.75M shares derived: average of 2 quarters · filed 2024-11-12 | 152.78M shares 10-Q · filed 2024-11-12 | 158.44M shares 10-Q · filed 2023-11-09 | 158.26M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 152.80M shares 10-Q · filed 2024-08-12 | 152.78M shares 10-Q · filed 2024-08-12 | 152.78M shares derived: average of 3 quarters · filed 2024-08-12 | 152.78M shares derived: average of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | 152.78M shares 10-Q · filed 2024-05-09 | 152.78M shares derived: average of 2 quarters · filed 2024-05-09 | 152.78M shares derived: average of 3 quarters · filed 2024-05-09 | 152.77M shares derived: average of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | 152.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | 152.77M shares derived: average of 2 quarters · filed 2024-03-07 | 152.77M shares derived: average of 3 quarters · filed 2024-03-07 | 152.77M shares 10-K · filed 2024-03-07 | ||
| 2022-09-30 | 152.77M shares 10-Q · filed 2023-11-09 | 152.77M shares derived: average of 2 quarters · filed 2023-11-09 | 152.77M shares 10-Q · filed 2023-11-09 | 152.78M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 152.77M shares 10-Q · filed 2023-08-10 | 152.77M shares 10-Q · filed 2023-08-10 | 152.78M shares derived: average of 3 quarters · filed 2023-08-10 | 152.73M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 152.77M shares 10-Q · filed 2023-05-15 | 152.79M shares derived: average of 2 quarters · filed 2023-05-15 | 152.72M shares derived: average of 3 quarters · filed 2023-05-15 | 152.66M shares derived: average of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | 152.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | 152.70M shares derived: average of 2 quarters · filed 2023-03-30 | 152.62M shares derived: average of 3 quarters · filed 2023-03-30 | 133.92M shares 10-K · filed 2023-03-30 | ||
| 2021-09-30 | 152.59M shares 10-Q · filed 2022-11-10 | 152.52M shares derived: average of 2 quarters · filed 2022-11-10 | 127.62M shares 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | 152.46M shares 10-Q · filed 2022-08-11 | 114.93M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |